Streetbeat News

Regulatory

VJET

Voxeljet (NASDAQ:VJET) has been selected by GE Research for a $14.9M contract funded by the U.S. Department of Energy (DoE) to develop advanced manufacturing technologies. The project aims to develop a voxeljet sand binder jet 3D printer for manufacturing large sand-casting molds, which will be used to produce metallic near net shape (NNS) components for the wind and hydro energy sectors. The goal is to reduce production time and costs, with the potential to reduce overall hydropower costs by 20% and lead times by four months.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:16 pm

BCT

BCTX

BCTXW

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW) (TSX:BCT) will host a virtual Key Opinion Leader (KOL) event on October 26, 2023, to discuss the potential of Bria-IMT™ in advanced metastatic breast cancer. The event will feature Dr. Adam M. Brufsky from the University of Pittsburgh School of Medicine and Dr. Saranya Chumsri from Mayo Clinic. BriaCell recently reported patient survival and clinical benefit with median overall survival of 13.5 months in BriaCell's advanced metastatic breast cancer patients. Bria-IMT™ has been awarded Fast Track status by the U.S Food and Drug Administration for the treatment of advanced metastatic breast cancer and initiated a phase 3 pivotal registration study.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:11 pm

INO

Inovio Pharmaceuticals Inc's stock is surging after the FDA allowed the company to use data from the completed Phase 1/2 trial of INO-3107 for a Biological License Application (BLA) for accelerated approval. The company will not need to conduct a planned Phase 3 trial for the submission. However, a confirmatory trial will be required before the submission. If approved, INO-3107 would be the first DNA medicine in the U.S. and the first Inovio candidate to be approved.

Portfolio Pulse from Adam Eckert

October 11, 2023 | 1:07 pm

EIS

META

VGK

The EU's tech regulator has warned Meta Platforms Inc's CEO Mark Zuckerberg over a surge in disinformation, particularly related to the Israel-Hamas conflict. The regulator has expressed concerns over the company's ability to manage and control such content.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:06 pm

PLUG

Plug Power Inc (NASDAQ:PLUG) shares are trading higher after the company disclosed new information in a regulatory filing and ahead of its annual symposium. The company expects strong gross margin expansion through 2030 and has made investments to capture the planned hydrogen push. The company also provided a long-term revenue outlook, including expectations for $1.2 billion in revenue this year, $6 billion in 2027 and $20 billion in 2030. Plug Power also signed a memorandum of understanding with Fortescue to evaluate the potential supply of equipment for green hydrogen production projects across North America.

Portfolio Pulse from Adam Eckert

October 11, 2023 | 1:04 pm

EIS

The conflict between Israel and Hamas is escalating, with international actors becoming involved. Hezbollah, an Iranian-backed militia, has launched missiles from Lebanon, and the head of the Kataib Hezbollah militia has threatened to target American bases if the US intervenes. US Secretary of State Antony Blinken is due to visit Israel to express support, and the US has delivered advanced ammunition to Israel. Treasury Secretary Janet Yellen has suggested that further sanctions on Iran may be imposed. The Israeli shekel has weakened by 0.2%, and the iShares MSCI Israel ETF (NYSE:EIS) fell 0.9% on Wednesday.

Portfolio Pulse from Piero Cingari

October 11, 2023 | 1:03 pm

SINT

SINTX Technologies has been awarded a Phase II grant of $1,972,826 by the National Institutes of Health (NIH) to develop a 3D printed composite silicon nitride – polyetheretherketone (SN-PEEK) spinal implant. This is the fourth NIH grant awarded to SINTX. The company will collaborate with the University of Pennsylvania School of Veterinary Medicine over the next 24 months to execute this project. The NIH grant will support resourcing and acquisition of materials as well as testing and trials at SINTX and Penn Vet.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:02 pm

LXRX

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) announced that findings from two studies on the cost-effectiveness and budget impact of INPEFA, a drug recently approved by the FDA for heart failure treatment, will be presented at the Academy of Managed Care Pharmacy Nexus 2023 National Meeting. The company believes that the cost-effectiveness analysis and budget impact model for INPEFA will be crucial in driving decisions for formulary inclusion of this innovation.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:01 pm

EGPT

EIS

SPY

Egypt has discussed with the U.S. its plans to provide aid through its border with Gaza under a limited ceasefire, according to Egyptian security sources cited by Reuters.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:00 pm

MA

V

Mastercard's CFO, Sachin Mehra, has expressed concerns about the financial sustainability of India's Unified Payments Interface (UPI), despite its role in promoting digital transactions. The zero-cost transaction model of UPI has raised concerns about its long-term viability. This has been a concern for global card giants like Mastercard and Visa, who find it challenging to penetrate a market dominated by a cost-effective and government-supported payment system.

Portfolio Pulse from Anusuya Lahiri

October 11, 2023 | 12:49 pm